BioMarin Pharmaceutical, Inc. (BMRN)
56.20
+0.70
(+1.27%)
USD |
NASDAQ |
Apr 06, 16:00
56.20
0.00 (0.00%)
After-Hours: 16:08
BioMarin Pharmaceutical Total Liabilities (Quarterly) : 1.507B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| Ionis Pharmaceuticals, Inc. | 3.035B |
| Mirum Pharmaceuticals, Inc. | 528.12M |
| Hims & Hers Health, Inc. | 1.614B |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.594B |
| Shareholders Equity (Quarterly) | 6.087B |
| Debt to Equity Ratio | 0.1056 |
| Current Ratio | 5.179 |
| Net Debt Paydown Yield | -0.06% |